FREE

FREE
Download RealTimes for free and create stories of your photos and videos auto-magically!

Female Smokers At Higher Risk Of Heart Disease

. Thursday, August 25, 2011
0 comments


Featured Article
Academic Journal
Main Category: Smoking / Quit Smoking
Also Included In: Heart Disease;  Women's Health / Gynecology
Article Date: 11 Aug 2011 - 8:00 PDT window.fbAsyncInit = function() { FB.init({ appId: 'aa16a4bf93f23f07eb33109d5f1134d3', status: true, cookie: true, xfbml: true, channelUrl: 'http://www.medicalnewstoday.com/scripts/facebooklike.html'}); }; (function() { var e = document.createElement('script'); e.async = true; e.src = document.location.protocol + '//connect.facebook.net/en_US/all.js'; document.getElementById('fb-root').appendChild(e); }()); email icon email to a friend   printer icon printer friendly   write icon opinions  
5 starsnot yet rated
Women who smoke have a 25% higher risk of heart disease than men who smoke, and the longer they smoke, the bigger this risk becomes relative to men who smoke for the same number of years, according to a new pooled data study published today, 11 August in The Lancet. The researchers suggest physiological differences between the sexes, or perhaps because women smoke differently to men, means women are more strongly affected by the cancer-causing chemicals in tobacco smoke.

The British Heart Foundation said they found the study's results "alarming", especially as women tend to smoke fewer cigarettes than men, reports BBC News.

Dr Rachel R. Huxley, of the division of epidemiology at the University of Minnesota, and Dr Mark Woodward, of Johns Hopkins University in Maryland, both in the US, conducted a systematic review and meta-analysis of prospective cohort studies.

They reviewed studies that measured smoking and heart risk in men and women published between between 1966 and 2010 and found 75 data sets covering 2.4 million participants where researchers had done three things that met their criteria: (1) they had measured Relative Risk (RR) of coronary heart disease for men and women separately, (2) examined how it varied with current smoking compared with not smoking, and (3) adjusted for cardiovascular risk factors other than coronary heart disease.

When they analyzed the pooled data, Huxley and Woodward adjusted the figures to eliminate, as far as possible, the effect of sex differences in other major risk factors.

They expressed their results in RRRs: Relative Risk Ratios. The Relative Risk bit is the risk of a smoker developing heart disease, compared to a non-smoker. Then, by comparing results for men and women, they calculated ratios to express how the relative risk of being a smoker varies between the sexes.

Note that they did not take into account the number of cigarettes that men and women smoked, they just examined the risk of being a smoker relative to being a non-smoker.

They found that: The pooled, adjusted RRR of smoking compared with not smoking for coronary heart disease was 1.25 (95% CI ranged from 1·12 to 1·39, p<0·0001) for women relative to men, that is the women smokers showed a 25% higher chance of developing heart disease than their male smoking counterparts.
These figures were unchanged when they adjusted for publication bias and there was also little evidence that differences between studies (study-to-study hetergeneity, p=0.21) would be important enough to change the figures.
The increased Relative Risk among women went up by another 2% per year of follow-up, suggesting that the longer a woman smokes, the higher her risk of developing heart disease becomes, compared to a man who has smoked for the same number of years.The researchers also found data in 53 studies that had compared previous smokers with never smokers. When they pooled data from these, they found no evidence of a difference between men and women, comparing the relative risk of previous smokers with never smokers (RRR 0·96, 95% CI 0·86 to 1·08, p=0·53).

They concluded that it was not clear whether these differences in risk of coronary heart disease between men and women smokers are due to biology or differences in smoking behaviour.

"Tobacco-control programmes should consider women, particularly in those countries where smoking among young women is increasing in prevalence," they urged.

Written by Catharine Paddock PhD
Copyright: Medical News Today
Not to be reproduced without permission of Medical News Today

Article Reference:
"Cigarette smoking as a risk factor for coronary heart disease in women compared with men: a systematic review and meta-analysis of prospective cohort studies."
Rachel R Huxley, Mark Woodward.
The Lancet, 11 August 2011; DOI: 10.1016/S0140-6736(11)60781-2
link to Article

Additional source: BBC News.

Bookmark and Share

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:



MediLexicon International Ltd Logo
Privacy Policy | Terms and Conditions

MediLexicon International Ltd
Bexhill-on-Sea, UK
MediLexicon International Ltd © 2004-2011 All rights reserved.



View the original article here

Stacy London's Saturday Style

.
0 comments

If that big moment has gotten a little lackluster, spice things up with these tips on how to have the best O ever! Read More

More Popular Stories on Health.com


View the original article here

Waist Circumference Not A Better Predictor Of Diabetes Risk Than Body Mass Index In U.S. Adolescents

.
0 comments


Main Category: Diabetes
Article Date: 20 Aug 2011 - 0:00 PDT window.fbAsyncInit = function() { FB.init({ appId: 'aa16a4bf93f23f07eb33109d5f1134d3', status: true, cookie: true, xfbml: true, channelUrl: 'http://www.medicalnewstoday.com/scripts/facebooklike.html'}); }; (function() { var e = document.createElement('script'); e.async = true; e.src = document.location.protocol + '//connect.facebook.net/en_US/all.js'; document.getElementById('fb-root').appendChild(e); }()); email icon email to a friend   printer icon printer friendly   write icon opinions  
not yet ratednot yet rated
Waist circumference, a measure of belly fat, is not a better predictor than body mass index for identifying children with an increased risk of developing type 2 diabetes, according to a study by University of Michigan researchers.

Results of the study, led by U-M C.S. Mott Children's Hospital pediatric endocrinologist Joyce M. Lee, M.D., M.P.H., appear online today ahead of print in the Journal of Adolescent Health.

Increases in obesity and type 2 diabetes in children and adolescents in the United States have led to increased interest in early identification of high-risk children, including those with high insulin levels, as they have an increased risk for developing type 2 diabetes.

The predictor used most widely in the primary care setting and which has been recommended by the American Academy of Pediatrics is body mass index, also known as BMI.

"There is increasing interest in measuring waist circumference in children to assess for chronic disease risk," says Lee, a member of the Child Health Evaluation and Research (CHEAR) Unit. "Providers may be unsure of whether they should be measuring body mass index, weight circumference or both to determine those risks."

"Waist circumference measures excess fat around the belly, which is an important risk factor for type 2 diabetes," Lee adds. "It has been suggested that waist circumference should be used instead of BMI for prediction of diabetes risk than obesity."

Using data from the National Health and Nutrition Examination Survey from 1999-2002, U-M researchers evaluated BMI, waist circumference, fasting glucose and insulin levels in an ethnically diverse sample of 1,571 adolescents.

Researchers found that close to 12% of the study population had insulin resistance and that BMI and waist circumference were equivalent in their ability to identify children with insulin resistance, a risk factor for diabetes.

"Waist circumference does not seem to provide a distinct advantage over BMI for identifying high-risk adolescents. Our findings suggest that further studies are needed before waist circumference is included as part of routine pediatric primary care screening," Lee says.

Currently, the AAP recommends that primary care providers use BMI as a screening tool for identifying overweight and obese children. Based on their findings, Lee and colleagues suggest that national organizations that issue screening guidelines should continue to encourage providers to focus on solely on BMI measurement for now.

Source: University of Michigan Health System

Bookmark and Share

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:



MediLexicon International Ltd Logo
Privacy Policy | Terms and Conditions

MediLexicon International Ltd
Bexhill-on-Sea, UK
MediLexicon International Ltd © 2004-2011 All rights reserved.



View the original article here

Majority Of Pharmaceutical Ads Do Not Adhere To FDA Guidelines

.
0 comments


View the original article here

Mass Media Messages And Fat-Stigma

.
0 comments


Main Category: Obesity / Weight Loss / Fitness
Also Included In: Women's Health / Gynecology;  Psychology / Psychiatry
Article Date: 18 Aug 2011 - 0:00 PDT window.fbAsyncInit = function() { FB.init({ appId: 'aa16a4bf93f23f07eb33109d5f1134d3', status: true, cookie: true, xfbml: true, channelUrl: 'http://www.medicalnewstoday.com/scripts/facebooklike.html'}); }; (function() { var e = document.createElement('script'); e.async = true; e.src = document.location.protocol + '//connect.facebook.net/en_US/all.js'; document.getElementById('fb-root').appendChild(e); }()); email icon email to a friend   printer icon printer friendly   write icon opinions  
3 and a half stars3 stars
Women harbor a fat-stigma even though their family and closest friends may not judge them as "fat," according to findings by Arizona State University social scientists. Those research results, published Aug. 17 in the journal Social Science & Medicine, have scientists questioning the weight of messages from sources outside one's social networks, especially those in mass media marketing.

"We found that women generally missed the mark when estimating what their friends and family thought about their weight," said Daniel J. Hruschka, an ASU cultural anthropologist and co-author of the study. "Women were a bit more attuned to the views of close friends and family, but even then, they generally perceived the judgments of others inaccurately."

For this study, the ASU researchers interviewed 112 women aged 18-45 living in Phoenix, Arizona, and 823 others in their family and social networks. The focus was to understand how and why fat-stigma is distributed in the context of everyday interactions and relationships, and test some key ideas about how perceptions of stigma are amplified or mitigated by women's relationships in the framework of their social networks.

Lead author of the study, Alexandra Brewis, a biological anthropologist and director of ASU's Center for Global Health, noted that while obesity is a major medical and public health challenge, the stigma attached to it also creates suffering and needs to be examined. According to the ASU findings, urging family and friends to be less judgmental may be of little assistance in alleviating the stigma.

"Fat is understood culturally to represent profound personal failing and the attendant moral messages attached to it include laziness, lack of self-control, and being undesirable or even repulsive," the authors wrote. "So powerful and salient are these anti-fact messages that some Americans say they would rather die years sooner or be completely blind than be thought of as obese."

"The question this leaves us with is: 'If it isn't the opinions of friends and family that make us feel so bad about being overweight, then what does?' What seems most likely is that media and pop cultural messages are so pervasive and powerful that even the most loving support of those closest to us provides only limited protection against them," said Brewis, who also is a professor and executive director of the School of Human Evolution and Social Change in ASU's College of Liberal Arts and Sciences.

The findings are published in an article titled "Vulnerability to fat-stigma in women's everyday relationships." In addition to Brewis and Hruschka, the third author is Amber Wutich. Hruschka and Wutich are assistant professors in ASU's School of Human Evolution and Social Change. Some 40 ASU undergraduate global health students assisted with parts of the study.

Bookmark and Share

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:



MediLexicon International Ltd Logo
Privacy Policy | Terms and Conditions

MediLexicon International Ltd
Bexhill-on-Sea, UK
MediLexicon International Ltd © 2004-2011 All rights reserved.



View the original article here

Drink Wine To Beat Dementia Risk, But Find The Balance Study Reports

. Wednesday, August 24, 2011
0 comments


Editor's Choice
Main Category: Alzheimer's / Dementia
Also Included In: Nutrition / Diet;  Alcohol / Addiction / Illegal Drugs
Article Date: 19 Aug 2011 - 2:00 PDT window.fbAsyncInit = function() { FB.init({ appId: 'aa16a4bf93f23f07eb33109d5f1134d3', status: true, cookie: true, xfbml: true, channelUrl: 'http://www.medicalnewstoday.com/scripts/facebooklike.html'}); }; (function() { var e = document.createElement('script'); e.async = true; e.src = document.location.protocol + '//connect.facebook.net/en_US/all.js'; document.getElementById('fb-root').appendChild(e); }()); email icon email to a friend   printer icon printer friendly   write icon opinions  
4 stars4 and a half stars
For over thirty years research has been done and much debate has carried on about the benefits or risks associated with drinking alcohol and wine in particular. After an analysis of research since 1977, it has been determined that drinking moderate amounts of alcohol, especially wine, may lower the risk of dementia which often leads to severe Alzheimer's Disease. Too much increases the risk so balance is necessary.

As a matter of fact, the association between moderate drinking and reduced risk of dementia and cognitive impairment was statistically significant in 14 of 19 countries, including the United States.

Resveratrol, found in wine at fairly high levels, is a naturally occurring antioxidant too that decreases the stickiness of blood platelets and helps blood vessels remain open and flexible. It is also known that it inhibits the enzymes that can stimulate cancer cell growth and suppress immune response.

Wine is the primary dietary source of resveratrol, and red wine contains much greater amounts of resveratrol than does white wine, since resveratrol is concentrated in the grape skin and the manufacturing process of red wine includes prolonged contact with grape skins.

Edward J. Neafsey, a professor in the department of molecular pharmacology and therapeutics at Loyola University Medical Center said:

"We don't recommend that nondrinkers start drinking. But moderate drinking, if it is truly moderate, can be beneficial."

Moderate drinkers were 23% less likely to develop dementia, Alzheimer's disease and other forms of cognitive impairment, but don't get it twisted or see this fact as a reprieve to drink heavily. More than three to five drinks per day was associated with a higher risk of dementia and cognitive impairment.

Dr. Sam Gandy, chair in Alzheimer's disease Research and professor of neurology at the Mount Sinai Alzheimer's Disease Research Center, Mount Sinai School of Medicine in New York City continues:

"This study was well-designed and well-executed but falls in the category of epidemiology [population wide, observational studies]. There are at least a dozen reports such as this, touting the beneficial neurological effects of alcohol. Each report brings calls and visits from patients, interested in what advice they can take away and apply to their own lives. Until there are some randomized clinical trial data, no patient guidance is warranted."

It is true however that it isn't clear why moderate drinking may reduce the risk of dementia and cognitive impairment, but one school of thought suggests that alcohol might improve blood flow in the brain and thus brain metabolism which keeps the brain sharp. Learning multiple languages has the same effect.

Dr. James Galvin, director of the Pearl Barlow Center for Memory Evaluation and Treatment at NYU Langone Medical Center in New York City points out many things one can do to stave off the onset of dementia:

"The Mediterranean diet with whole grains, fresh fruit and vegetables, olive oil and moderate red wine also reduces the risk of dementia, as does exercise, social engagement, mental activities and an optimistic outlook on life. It is clear that heart healthy behaviors are also brain healthy behaviors."

Written by Sy Kraft
Copyright: Medical News Today
Not to be reproduced without permission of Medical News Today

Article Reference:
"Moderate alcohol consumption and cognitive risk"
The Journal of Neuropsychiatric Disease and Treatment
Edward J Neafsey, Michael A Collins Department of Molecular Pharmacology and Therapeutics
Loyola University Chicago, Stritch School of Medicine, Maywood, IL, USA Bookmark and Share

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:



MediLexicon International Ltd Logo
Privacy Policy | Terms and Conditions

MediLexicon International Ltd
Bexhill-on-Sea, UK
MediLexicon International Ltd © 2004-2011 All rights reserved.



View the original article here

Malaria Eradication Threatened By Insecticide Resistance

.
0 comments


Editor's Choice
Main Category: Tropical Diseases
Also Included In: Infectious Diseases / Bacteria / Viruses;  Immune System / Vaccines
Article Date: 19 Aug 2011 - 9:00 PDT window.fbAsyncInit = function() { FB.init({ appId: 'aa16a4bf93f23f07eb33109d5f1134d3', status: true, cookie: true, xfbml: true, channelUrl: 'http://www.medicalnewstoday.com/scripts/facebooklike.html'}); }; (function() { var e = document.createElement('script'); e.async = true; e.src = document.location.protocol + '//connect.facebook.net/en_US/all.js'; document.getElementById('fb-root').appendChild(e); }()); email icon email to a friend   printer icon printer friendly   write icon opinions  
not yet ratednot yet rated
Findings, published Online First in The Lancet Infectious Diseases, indicate an urgent need for new strategies to mitigate the potentially devastating effects of insecticide resistance on malaria control in Africa. Research in Senegal discovered, that growing resistance to a common class of insecticide by Anopheles gambiae (African mosquito that transmits malaria) in connection with increasing susceptibility of older children and adults has resulted in a resurgence of malaria. Older children and adults are possibly more susceptible because their protective immunity is decreased due to a lack of exposure to malaria.

Although introducing artemisinin-combination therapies (ACTs) and widespread distribution of insecticide-treated mosquito-nets achieved major reductions in malaria transmission in Africa, little is known about the extent to which these interventions might reduce malaria morbidity in the long-term.

Recent reports from Africa indicate that resistance to common pythethroid insecticides is on the rise. Seeing that there are few effective and inexpensive alternative insecticides safe for humans, this rise causes serious implications for malaria control strategies, particularly as there are few alternative insecticides that are effective, inexpensive, and safe for humans.

Jean-François Trape from the Institut de Recherche pour le Développement in Dakar, Senegal and his team assessed the consequences of introducing ACTs as the first-line treatment for malaria (June 2006) and the roll-out of long-lasting insecticide (deltamethrin*)-treated mosquito-nets (LLINs; July 2008) in a rural west African population.

Researchers collected data on malaria morbidity, mosquito populations and asymptomatic infections in the Senegalian village of Dielmo for 1.5 years before the scale-up of LLINs and 2.5 years after. Between August 2008 and August 2010, they discovered a marked reduction in malaria attacks after the distribution of LLINs, however, 27-30 months after the roll out (Sept. and Dec. 2010), the attacks increased to even higher levels than before the introduction of LLINs in adults and older children.

In 2010, the researchers also discovered a 37% resistance of A gambiae mosquitoes to deltamethrin and that the kdr mutation (conferring resistance to pythethroid insecticides) increased by 40% in 3 years (from 8% in 2007 to 48% in 2010).

Researchers believe that the "rebound" in malaria attacks in older children and adults was the result of a combination of lowered immunity because of a lack of exposure to malaria** due to intervention-suppressed transmission and insecticide resistance that increased exposure to A gambiae mosquitoes.

They authors conclude,

"These findings are of great concern, since they support the idea that insecticide resistance might not permit a substantial decrease in malaria morbidity in many parts of Africa where A gambiae is the major vector and acquired clinical immunity is a key epidemiological factor."

Joseph Keating and Thomas Eisele from Tulane University in New Orleans, USA, stress the need for caution before making the assumption that these results apply to other African regions. In a comment they said,

"The study was done over a short period of time (4 years) which restricts any attempt to differentiate between short-term heterogeneity in malaria transmission and long-term shifts in malaria epidemiology...[and] also raises questions about how fast an individual previously exposed to stable transmission (i.e., before the scale-up of malaria control) loses their acquired immunity, especially in adults with decades of exposure to repeated malaria parasite infections."
Written by Petra Rattue
Copyright: Medical News Today
Not to be reproduced without permission of Medical News Today Article Reference:
”Malaria morbidity and pyrethroid resistance after the introduction of insecticide-treated bednets and artemisinin-based combination therapies: a longitudinal study”
Dr Jean-François Trape MD et al.
The Lancet Infectious DiseasesBookmark and Share

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:



MediLexicon International Ltd Logo
Privacy Policy | Terms and Conditions

MediLexicon International Ltd
Bexhill-on-Sea, UK
MediLexicon International Ltd © 2004-2011 All rights reserved.



View the original article here

Improved Diagnostics Could Reduce Risky Surgery For Asymptomatic Carotid Stenosis

.
0 comments


Main Category: Cardiovascular / Cardiology
Also Included In: Stroke
Article Date: 19 Aug 2011 - 0:00 PDT window.fbAsyncInit = function() { FB.init({ appId: 'aa16a4bf93f23f07eb33109d5f1134d3', status: true, cookie: true, xfbml: true, channelUrl: 'http://www.medicalnewstoday.com/scripts/facebooklike.html'}); }; (function() { var e = document.createElement('script'); e.async = true; e.src = document.location.protocol + '//connect.facebook.net/en_US/all.js'; document.getElementById('fb-root').appendChild(e); }()); email icon email to a friend   printer icon printer friendly   write icon opinions  
not yet ratednot yet rated
New research from Neurologist Dr. David Spence of The University of Western Ontario has shown that using 3-D ultrasound to identify ulcers in the carotid arteries is an effective way to pinpoint the small number of high-risk patients with asymptomatic carotid stenosis (ACS) who would benefit from surgery to prevent stroke. ACS is a blocking or narrowing of the carotid artery in the neck from which there have been no symptoms such as transient ischemic attacks (TIAs). The research is published in the August 17th online issue of Neurology, the medical journal of the American Academy of Neurology.

In the three-year study of ACS patients, Dr. Spence found that if three or more ulcers were found in the carotid arteries using 3D ultrasound, the patient was at high risk of stroke and could benefit from intervention. He compared it to the proven transcranial Doppler which detects pieces of plaque called microemboli breaking off and entering the blood stream, and found both identified those ACS patients most at risk of having a stroke.

Surgical interventions such as stenting where a stent is threaded from an artery in the groin up to the narrowed carotid artery and then deployed, and carotid endarterectomy, where the blocked artery is opened and the plaque cleaned out, both carry their own risks and costs. Dr. Spence showed in earlier studies (2005) that 90 per cent of patients with ACS were better off being treated with medical therapy. With more intensive medical therapy, the proportion who could benefit from intervention had declined by 2010 to less than five per cent.

"Now we've developed two ways to identify the few who could benefit from surgery or stenting," says Dr. Spence, a Professor in the Department of Clinical Neurological Sciences at Western's Schulich School of Medicine & Dentistry and a scientist in its Robarts Research Institute. "The reason it's important is that in the United States 90 to 95 per cent of carotid endarterectomy and stenting are being done for asymptomatic carotid stenosis even though it's not warranted for the vast majority of them. I hope this study would influence those decisions."

The study was funded by the Heart and Stroke Foundation of Canada. "Thanks to this effort, we are that much closer to providing ways to improve system care for stroke patients," says Manuel Arango, Director, Health Policy, Heart and Stroke Foundation of Canada.

Dr. Spence is also the Director of the Stroke Prevention & Atherosclerosis Research Centre (SPARC) at University Hospital, London Health Sciences Centre.

Bookmark and Share

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:



MediLexicon International Ltd Logo
Privacy Policy | Terms and Conditions

MediLexicon International Ltd
Bexhill-on-Sea, UK
MediLexicon International Ltd © 2004-2011 All rights reserved.



View the original article here